Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Guoping Pharmaceutical Co., Ltd. is a national high-tech enterprise based in Hefei, China, specializing in the research, development, production, and sales of peptide products and related technologies. Founded in 2017, the company has established itself as a leading professional production enterprise for peptide synthesis, antibody preparation, and protein expression. Its core capabilities include solid-phase and liquid-phase peptide synthesis, isotope labeling, stapled peptides, and advanced purification techniques. Guoping Pharmaceutical provides a wide range of products, including custom and catalog peptides, drug peptides, and cosmetic peptides, which are utilized in oncology, diabetes, and cardiovascular research. The company also operates a dedicated new drug R&D center and collaborates with academic institutions like China Pharmaceutical University on innovative peptide delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Guoping Pharmaceutical.